Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 3453059, 17 pages
http://dx.doi.org/10.1155/2016/3453059
Research Article

Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS Expression

1Department of Anesthesiology, The First Hospital of Jilin University, Jilin 130021, China
2Department of Anesthesiology, The University of Hong Kong, Pokfulam, Hong Kong
3Department of Pharmacology and Pharmacy and State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong
4School of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong Kong

Received 1 June 2016; Revised 9 August 2016; Accepted 8 September 2016

Academic Editor: Qingping Feng

Copyright © 2016 Lei Pang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Moran, M. H. Forouzanfar, G. A. Roth et al., “The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study,” Circulation, vol. 129, no. 14, pp. 1493–1501, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Hausenloy and D. M. Yellon, “Myocardial ischemia-reperfusion injury: a neglected therapeutic target,” The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Xia, Y. Chen, Q. Fan, and M. Xue, “Oxidative stress-mediated reperfusion injury: mechanism and therapies,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 373081, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Marnett, S. W. Rowlinson, D. C. Goodwin, A. S. Kalgutkar, and C. A. Lanzo, “Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition,” The Journal of Biological Chemistry, vol. 274, no. 33, pp. 22903–22906, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S.-K. Wong and P. M. Vanhoutte, “COX-mediated endothelium-dependent contractions: from the past to recent discoveries,” Acta Pharmacologica Sinica, vol. 31, no. 9, pp. 1095–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Pang, Y. Cai, E. H. Tang, M. G. Irwin, H. Ma, and Z. Xia, “Prostaglandin E receptor subtype 4 signaling in the heart: role in ischemia/reperfusion injury and cardiac hypertrophy,” Journal of Diabetes Research, vol. 2016, Article ID 1324347, 10 pages, 2016. View at Publisher · View at Google Scholar
  7. C. A. Rouzer and L. J. Marnett, “Cyclooxygenases: structural and functional insights,” The Journal of Lipid Research, vol. 50, supplement, pp. S29–S34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Schrör, K. C. Zimmermann, and R. Tannhäuser, “Augmented myocardial ischaemia by nicotine—mechanisms and their possible significance,” British Journal of Pharmacology, vol. 125, no. 1, pp. 79–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Y. Wong, M. Fukuchi, P. Melnyk, I. Rodger, and A. Giaid, “Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure,” Circulation, vol. 98, no. 2, pp. 100–103, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Shinmura, Y.-T. Xuan, X.-L. Tang et al., “Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning,” Circulation Research, vol. 90, no. 5, pp. 602–608, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Rossoni, M. N. Muscara, G. Cirino, and J. L. Wallace, “Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit,” British Journal of Pharmacology, vol. 135, no. 6, pp. 1540–1546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Lada-Moldovan, S. Kaloustian, T. M. Bah, S.-A. Girard, M.-A. Déry, and G. Rousseau, “Chronic pretreatment with celecoxib reduces infarct size,” Journal of Cardiovascular Pharmacology, vol. 54, no. 1, pp. 31–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Saito, I. W. Rodger, H. Shennib, F. Hu, L. Tayara, and A. Giaid, “Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor,” Canadian Journal of Physiology and Pharmacology, vol. 81, no. 2, pp. 114–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Saeed and S. Ahmed, “Role of cyclooxygenase-2 in myocardial infarction and ischaemia,” Journal of the College of Physicians and Surgeons Pakistan, vol. 16, no. 5, pp. 324–328, 2006. View at Google Scholar · View at Scopus
  15. A. Carnieto Jr., P. M. M. Dourado, P. L. D. Luz, and A. C. P. Chagas, “Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia,” Clinics, vol. 64, no. 3, pp. 245–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Kunak, O. Kukula, E. Mutlu et al., “The effect of etoricoxib on hepatic ischemia-reperfusion injury in rats,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 598162, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. D. McCully, H. Wakiyama, Y.-J. Hsieh, M. Jones, and S. Levitsky, “Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 5, pp. H1923–H1935, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Gottlieb, K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler, “Reperfusion injury induces apoptosis in rabbit cardiomyocytes,” The Journal of Clinical Investigation, vol. 94, no. 4, pp. 1621–1628, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Badalzadeh, B. Mokhtari, and R. Yavari, “Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus,” Journal of Physiological Sciences, vol. 65, no. 3, pp. 201–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Abbate, D. Santini, G. G. L. Biondi-Zoccai et al., “Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?” Heart, vol. 90, no. 4, pp. 440–443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-E. St-Germain, V. Gagnon, I. Mathieu, S. Parent, and E. Asselin, “Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells,” International journal of oncology, vol. 24, no. 5, pp. 1311–1324, 2004. View at Google Scholar · View at Scopus
  22. S. Lei, H. Li, J. Xu et al., “Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling,” Diabetes, vol. 62, no. 7, pp. 2318–2328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Lei, W. Su, H. Liu et al., “Nitroglycerine-induced nitrate tolerance compromises propofol protection of the endothelial cells against TNF-α: the role of PKC-β2 and nadph oxidase,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 678484, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Li, W. Yao, M. G. Irwin et al., “Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1,” Free Radical Biology and Medicine, vol. 84, pp. 311–321, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Lyß, A. Knorre, T. J. Schmidt, H. L. Pahl, and I. Merfort, “The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65,” The Journal of Biological Chemistry, vol. 273, no. 50, pp. 33508–33516, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Schuligoi, R. Amann, C. Prenn, and B. A. Peskar, “Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells,” Inflammation Research, vol. 47, no. 5, pp. 227–230, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Qiao, X. Mao, Y. Wang et al., “Remifentanil preconditioning reduces postischemic myocardial infarction and improves left ventricular performance via activation of the Janus activated kinase-2/signal transducers and activators of transcription-3 signal pathway and subsequent inhibition of glycogen synthase kinase-3β in rats,” Critical Care Medicine, vol. 44, no. 3, pp. e131–e145, 2016. View at Publisher · View at Google Scholar
  28. R. Xue, S. Lei, Z.-Y. Xia et al., “Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways,” Clinical Science, vol. 130, no. 5, pp. 377–392, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Cai, G. K. Sukhova, H. K. Wong et al., “Rap1 induces cytokine production in pro-inflammatory macrophages through NFκB signaling and is highly expressed in human atherosclerotic lesions,” Cell Cycle, vol. 14, no. 22, pp. 3580–3592, 2015. View at Publisher · View at Google Scholar
  30. Y. Cai, F. Ying, E. Song et al., “Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance,” The FASEB Journal, vol. 29, no. 12, pp. 4924–4936, 2015. View at Publisher · View at Google Scholar
  31. Y. Liu, J. Jin, S. Qiao et al., “Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling,” Clinical Science, vol. 129, no. 4, pp. 331–344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Liu, G. Wang, J. Yang, X. Pan, Z. Yang, and L. Zang, “Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes,” PLoS ONE, vol. 6, no. 6, Article ID e21416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Stæhr, K. Madsen, P. M. Vanhoutte, P. B. Hansen, and B. L. Jensen, “Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 301, no. 2, pp. R412–R420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. J. Crofford, B. Tan, C. J. McCarthy, and T. Hla, “Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes,” Arthritis & Rheumatism, vol. 40, no. 2, pp. 226–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. K.-M. Lee, B.-S. Kang, H.-L. Lee et al., “Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity,” European Journal of Neuroscience, vol. 19, no. 12, pp. 3375–3381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Legrand, J. M. Bour, C. Jacob et al., “Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected],” Journal of Biotechnology, vol. 25, no. 3, pp. 231–243, 1992. View at Google Scholar
  37. A. Saraste, “Morphologic criteria and detection of apoptosis,” Herz, vol. 24, no. 3, pp. 189–195, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Ricciotti and G. A. Fitzgerald, “Prostaglandins and inflammation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 986–1000, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Braunersreuther and V. Jaquet, “Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches,” Current Pharmaceutical Biotechnology, vol. 13, no. 1, pp. 97–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Matsui, J. Tao, F. Del Monte et al., “Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo,” Circulation, vol. 104, no. 3, pp. 330–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Oh, T.-J. Lee, J.-W. Park, and T. K. Kwon, “Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-κB in RAW 264.7 cells,” European Journal of Pharmacology, vol. 599, no. 1–3, pp. 11–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Bolli, “Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 11, pp. 1897–1918, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Joldersma, E. H. Burger, C. M. Semeins, and J. Klein-Nulend, “Mechanical stress induces COX-2 mRNA expression in bone cells from elderly women,” Journal of Biomechanics, vol. 33, no. 1, pp. 53–61, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. D. J. Granville, J. R. Shaw, S. Leong et al., “Release of cytochrome c, Bax migration, bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis,” The American Journal of Pathology, vol. 155, no. 4, pp. 1021–1025, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Burlacu, “Regulation of apoptosis by Bcl-2 family proteins,” Journal of Cellular and Molecular Medicine, vol. 7, no. 3, pp. 249–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Zhang, Y. Xia, Z. Xu, and X. Deng, “Propofol suppressed hypoxia/reoxygenation-induced apoptosis in HBVSMC by regulation of the expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1518738, 11 pages, 2016. View at Publisher · View at Google Scholar
  48. A. G. Porter and R. U. Jänicke, “Emerging roles of caspase-3 in apoptosis,” Cell Death and Differentiation, vol. 6, no. 2, pp. 99–104, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Chang, D. Zhang, J. Liu et al., “Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells,” Experimental Biology and Medicine, vol. 239, no. 4, pp. 414–422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Li, Y.-C. Cui, H. Zhang et al., “Glutamine reduces the apoptosis of H9C2 cells treated with high-glucose and reperfusion through an oxidation-related mechanism,” PLoS ONE, vol. 10, no. 7, Article ID e0132402, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. N. G. Frangogiannis, “Targeting the inflammatory response in healing myocardial infarcts,” Current Medicinal Chemistry, vol. 13, no. 16, pp. 1877–1893, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. P. Moodley, N. L. A. Misso, A. K. Scaffidi et al., “Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 4, pp. 490–498, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. S. B. Haudek, G. E. Taffet, M. D. Schneider, and D. L. Mann, “TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways,” The Journal of Clinical Investigation, vol. 117, no. 9, pp. 2692–2701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Wang, A. Shnyra, C. Africa, C. Warholic, and C. McArthur, “Activation of the extrinsic apoptotic pathway by TNF-α in Human Salivary Gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and Intercellular Adhesion Molecule-1 (ICAM-1) in Sjögren's Syndrome-associated autoimmune sialadenitis,” Archives of Oral Biology, vol. 54, no. 11, pp. 986–996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. Y.-M. Kim, R. V. Talanian, and T. R. Billiar, “Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms,” The Journal of Biological Chemistry, vol. 272, no. 49, pp. 31138–31148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. P. M. Vanhoutte, H. Shimokawa, M. Feletou, and E. Tang, “Endothelial dysfunction and vascular disease—a thirthieth anniversary update,” Acta Physiologica, 2016. View at Publisher · View at Google Scholar
  57. Y. Zhao, P. M. Vanhoutte, and S. W. S. Leung, “Vascular nitric oxide: beyond eNOS,” Journal of Pharmacological Sciences, vol. 129, no. 2, pp. 83–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Liu, Q. Qin, A. Bo, and etal, “The effect of sodium nitrite on induction of apoptosis in human gastric adenocarcinoma epithelia (AGS) cells,” Pharmacology & Pharmacy, vol. 6, no. 11, pp. 496–501, 2015. View at Publisher · View at Google Scholar
  59. X. Mao, T. Wang, Y. Liu et al., “N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats,” PLoS ONE, vol. 8, no. 7, Article ID e68949, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Wang, X. Mao, H. Li et al., “N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes,” Free Radical Biology and Medicine, vol. 63, pp. 291–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. A. M. Shah, “Inducible nitric oxide synthase and cardiovascular disease,” Cardiovascular Research, vol. 45, no. 1, pp. 148–155, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. I. N. Mungrue, R. Gros, X. You et al., “Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death,” The Journal of Clinical Investigation, vol. 109, no. 6, pp. 735–743, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. A. A. Bulhak, P.-O. Sjöquist, C.-B. Xu, L. Edvinsson, and J. Pernow, “Protection against myocardial ischaemia/reperfusion injury by PPAR-α activation is related to production of nitric oxide and endothelin-1,” Basic Research in Cardiology, vol. 101, no. 3, pp. 244–252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. D. V. Cuong, N. Kim, B. Y. Jae et al., “Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 290, no. 5, pp. H1808–H1817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. X.-Q. Tang, H.-M. Yu, J.-L. Zhi et al., “Inducible nitric oxide synthase and cyclooxgenase-2 mediate protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells,” Life Sciences, vol. 79, no. 9, pp. 870–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. P. Patel, W.-N. Qi, D. M. Allen et al., “Inhibition of iNOS with 1400W improves contractile function and alters NOS gene and protein expression in reperfused skeletal muscle,” Microsurgery, vol. 24, no. 4, pp. 324–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. Q. Tang, C. I. Svensson, B. Fitzsimmons, M. Webb, T. L. Yaksh, and X.-Y. Hua, “Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation,” European Journal of Neuroscience, vol. 25, no. 10, pp. 2964–2972, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. R. J. Grumont, I. J. Rourke, and S. Gerondakis, “Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis,” Genes & Development, vol. 13, no. 4, pp. 400–411, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. H. H. Lee, H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng, “NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9136–9141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Barkett and T. D. Gilmore, “Control of apoptosis by Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6910–6924, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Kaltschmidt, C. Kaltschmidt, T. G. Hofmann, S. P. Hehner, W. Dröge, and M. L. Schmitz, “The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus,” European Journal of Biochemistry, vol. 267, no. 12, pp. 3828–3835, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Fosslien, “Cardiovascular complications of non-steroidal anti-inflammatory drugs,” Annals of Clinical and Laboratory Science, vol. 35, no. 4, pp. 347–385, 2005. View at Google Scholar · View at Scopus
  74. S. Fries and T. Grosser, “The cardiovascular pharmacology of COX-2 inhibition,” Hematology/The Education Program of the American Society of Hematology, vol. 2005, no. 1, pp. 445–451, 2005. View at Google Scholar